Genta Inc

Document Sample
Genta Inc Powered By Docstoc
					Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Genta Inc
                                                                                          440 Wheelers Farms Road
                                                                                          Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in U.S. Dollars

                                 Wright Quality Rating:CDNN                                 Key Data

   Genta Incorporated (Genta) is a biopharmaceutical company engaged in                     Ticker:
   pharmaceutical (drug) research and development. The Company is engaged in the            GETA
   identification, development and commercialization of drugs for the treatment of
   cancer and related diseases. Its research portfolio consists of two major programs:      2009 Sales:
   Deoxyribonucleic Acid (DNA)/Ribonucleic Acid (RNA) Medicines, which includes its
                                                                                            218,000
   lead oncology drug, Genasense, and Small Molecules, which includes Genta's
   marketed product, Ganite, and tesetaxel and oral gallium-containing compounds. The
   DNA/RNA Medicines program includes drugs that are based on using modifications of        Major Industry:
   either DNA or RNA as drugs that can be used to treat disease. These technologies         Drugs, Cosmetics & Health
   include antisense, decoys, and small interfering or micro RNAs. It is also developing    Care
   tesetaxel as an oral agent that targets tubulin in cancer cells.
                       Stock Chart                                Officers                  Sub Industry:
                                                         Chairman & Chief Executive         Ethical Drug Manufacturers
                                                          Dr. Raymond P. Warrell Jr.
                                                                                            Country:
                                                              Senior Vice President &       United States
                                                              Chief Operating Officer
                                                                   W. L. Sanders            Currency:
                                                                                            U.S. Dollars
                                                              Vice President Finance,
                                                              Chief Financial Officer &
                                                                                            Fiscal Year Ends:
                                                                     Secretary
                                                              Gary Siegel(Interim CFO &     December
                                                                 Interim Secretary)
                                                                                            Employees
                                                                                            16

                                                                                            Exc
				
DOCUMENT INFO
Description: Genta Incorporated (Genta) is a biopharmaceutical company engaged in pharmaceutical (drug) research and development. The Company is engaged in the identification, development and commercialization of drugs for the treatment of cancer and related diseases. Its research portfolio consists of two major programs: Deoxyribonucleic Acid (DNA)/Ribonucleic Acid (RNA) Medicines, which includes its lead oncology drug, Genasense, and Small Molecules, which includes Genta's marketed product, Ganite, and tesetaxel and oral gallium-containing compounds. The DNA/RNA Medicines program includes drugs that are based on using modifications of either DNA or RNA as drugs that can be used to treat disease. These technologies include antisense, decoys, and small interfering or micro RNAs. It is also developing tesetaxel as an oral agent that targets tubulin in cancer cells.
BUY THIS DOCUMENT NOW PRICE: $39.95 100% MONEY BACK GUARANTEED
PARTNER Wright Investors' Service
Wright Investors' Service is an internationally recognized investment management and financial advisory firm headquartered in Milford, Connecticut. For more than 40 years, Wright has used well-defined and sophisticated investment strategies to help institutions, plan sponsors, bank trust departments, trust companies and individual investors achieve their financial objectives through a sensible approach to managing assets that balances risk and return.